Literature DB >> 27924140

Corrigendum: Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale".

Sabrina C Cecere¹, Sabrina Rossetti¹, Carla Cavaliere², Chiara Della Pepa¹, Marilena Di Napoli¹, Anna Crispo³, Gelsomina Iovane¹, Raffaele Piscitelli⁴, Domenico Sorrentino⁵, Gennaro Ciliberto⁶, Piera Maiolino⁴, Paolo Muto⁷, Sisto Perdonà⁵, Massimiliano Berretta⁸, Sandro Pignata¹, Gaetano Facchini¹, Carmine D'Aniello⁹.

Abstract

[This corrects the article on p. 287 in vol. 7, PMID: 27630568.].

Entities: Chemical Disease

Keywords: angiogenesis inhibitors; metastatic renal cancer; pazopanib; real world; treatment

Year: 2016 PMID： 27924140 PMCID： PMC5136557 DOI： 10.3389/fphar.2016.00468

Source DB: PubMed Journal: Front Pharmacol ISSN： 1663-9812 Impact factor: 5.810

In the original article, we have neglected to thank our funder, Novartis Farma S.p.A. The Funding Statement appears below.

Funding

Novartis Farma S.p.A. supported publication of this article. The authors apologize for this oversight. This error does not change the scientific conclusions of the article in any way.

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

3 in total

Review 1. Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer.

Authors: Carmine D'Aniello; Massimiliano Berretta; Carla Cavaliere; Sabrina Rossetti; Bianca Arianna Facchini; Gelsomina Iovane; Giovanna Mollo; Mariagrazia Capasso; Chiara Della Pepa; Laura Pesce; Davide D'Errico; Carlo Buonerba; Giuseppe Di Lorenzo; Salvatore Pisconti; Ferdinando De Vita; Gaetano Facchini
Journal: Front Oncol Date: 2019-12-11 Impact factor: 6.244

2. First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center.

Authors: Bin Wang; Ji-Wen Song; Hui-Qing Chen
Journal: Front Pharmacol Date: 2020-10-29 Impact factor: 5.810

3. Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature review.

Authors: Ying Chen; Xiaoming Ling; Wencui Kong; Shuiliang Wang; Zongyang Yu
Journal: Transl Cancer Res Date: 2020-04 Impact factor: 1.241

3 in total